Workflow
Tandem Diabetes Care(TNDM)
icon
Search documents
Tandem Diabetes Care(TNDM) - 2022 Q4 - Annual Report
2023-02-22 21:08
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________________ FORM 10-K _________________________________________________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36189 ______ ...
Tandem Diabetes Care(TNDM) - 2022 Q3 - Earnings Call Transcript
2022-11-03 00:16
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q3 2022 Results Conference Call November 2, 2022 4:30 PM ET Company Participants Susan Morrison - Executive VP & Chief Administrative Officer John Sheridan - President, CEO & Director Leigh Vosseller - EVP, CFO & Treasurer Conference Call Participants Matt Miksic - Barclays Brooks O'Neil - Lake Street Capital Partners Chris Pasquale - Nephron Research Matthew O'Brien - Piper Sandler Steve Litchman - Oppenheimer Matt Taylor - Jefferies Alex Nowak - Craig-Hallum Jayson ...
Tandem Diabetes Care(TNDM) - 2022 Q3 - Quarterly Report
2022-11-02 20:09
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________________________ FORM 10-Q _____________________________________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the T ...
Tandem Diabetes Care(TNDM) - 2022 Q2 - Earnings Call Transcript
2022-08-04 03:02
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Susan Morrison - Executive VP & Chief Administrative Officer John Sheridan - President, CEO & Director Brian Hansen - EVP & Chief Commercial Officer Leigh Vosseller - EVP, CFO & Treasurer Conference Call Participants Steven Lichtman - Oppenheimer Brooks O'Neil - Lake Street Capital Markets Travis Steed - Bank of America Merrill Lynch Jayson Bedford - Raymond James & Associates Matthew O'B ...
Tandem Diabetes Care(TNDM) - 2022 Q2 - Quarterly Report
2022-08-03 20:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________________________ FORM 10-Q _____________________________________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transi ...
Tandem Diabetes Care(TNDM) - 2022 Q1 - Earnings Call Transcript
2022-05-04 23:09
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Susan Morrison - EVP and Chief Administrative Officer John Sheridan - President and Chief Executive Officer Leigh Vosseller - EVP and Chief Financial Officer Conference Call Participants Steve Lichtman - Oppenheimer & Co Brooks O'Neil - Lake Street Capital Alex Nowak - Craig-Hallum Capital Jayson Bedford - Raymond James Danielle Antalffy - SVB Securities Jeff Johnson - Baird Disclaimer*: Thi ...
Tandem Diabetes Care(TNDM) - 2022 Q1 - Earnings Call Presentation
2022-05-04 21:15
MAY 4, 2022 Company Overview * Safe Harbor CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS Certain statements in this presentation constitute forward-looking statements, including, without limitation, statements about: the perceived advantages of our products relative to competitive products and technologies; our anticipated growth and other measures of future operating results and financial performance; the development and commercialization of new products; our ability to secure and maintain necessary ...
Tandem Diabetes Care(TNDM) - 2022 Q1 - Quarterly Report
2022-05-04 20:15
UNITED STATES SECURITIES AND EXCHANGE COMMISSION For the Transition Period from to Commission File Number 001-36189 _____________________________________________________________________________________________ Tandem Diabetes Care, Inc. (Exact name of registrant as specified in its charter) _____________________________________________________________________________________________ Washington, D.C. 20549 ____________________________________________________________________________________________ FORM 10-Q ...
Tandem Diabetes Care(TNDM) - 2021 Q4 - Earnings Call Transcript
2022-02-23 04:25
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q4 2021 Earnings Conference Call February 22, 2022 4:30 PM ET Company Participants Susan Morrison - EVP and CAO John Sheridan - President and CEO Leigh Vosseller - EVP and CFO Brian Hansen - EVP and Chief Commercial Officer Conference Call Participants Chris Pasquale - Guggenheim Brooks O'Neil - Lake Street Capital Alex Nowak - Craig-Hallum Capital Steve Lichtman - Oppenheimer and Company Matthew O'Brien - Piper Sandler Matt Taylor - UBS Danielle Antalffy - SVB Leeri ...
Tandem Diabetes Care(TNDM) - 2021 Q4 - Annual Report
2022-02-22 21:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________________ FORM 10-K _________________________________________________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36189 ______ ...